Journal Home
Search for

Volume 83, Issue 1, Pages 49-56 (April 2007)


View previous. 11 of 21 View next.

On the dose to a moving target while employing different IMRT delivery mechanisms

Eric D. Ehlera, Benjamin E. Nelmsc, Wolfgang A. ToméabCorresponding Author Informationemail address

Received 24 October 2006; received in revised form 26 January 2007; accepted 13 February 2007. published online 12 March 2007.

Abstract 

Background and purposes

To compare the temporal uniformity in dose delivered to a moving target for various intensity modulation radiotherapy (IMRT) modalities: solid intensity modulator (SIM), segmented multi-leaf collimator (SMLC), and dynamic multi-leaf collimator (DMLC).

Materials and methods

Two separate four-dimensional computed tomography data sets were obtained. Tumor motion kernels and motion envelopes were determined from composite positions of the tumor in various phases of the breathing cycle. Treatment plans were created for an unmodulated open field, SIM, SMLC, and DMLC. The motion envelope was treated as a static target volume. A robotic apparatus equipped with a diode array simulated the tumor motion in the plane of the beam’s eye view (BEV). Radiation was delivered to the moving target over ten trials for each modality. The average coefficient of variation (CV) was determined for each beam angle.

Results

The CV ranged from 0.09% to 0.15%, 0.23% to 3.14%, 1.14% to 5.51%, and 3.83% to 8.25% for the unmodulated open field, SIM, SMLC, and DMLC modalities, respectively. With gating, the CV was 0.23% to 2.31%, 0.31% to 2.97%, and 0.7% to 4.67% for SIM, SMLC, and DMLC, respectively.

Conclusion

SIM consistently provided the most temporally uniform dose to the moving target while DMLC provided the least. The SMLC and DMLC CV improved with gated delivery.

a Department of Medical Physics, and

b Department of Human Oncology, University of Wisconsin, Madison, WI, USA

c Canis Lupus LLC, St. Louis, MO, USA

Corresponding Author InformationCorresponding author. Wolfgang A. Tomé, Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, K4/344 CSC, 600 Highland Avenue, Madison, WI 53792, USA.

PII: S0167-8140(07)00063-1

doi:10.1016/j.radonc.2007.02.007


View previous. 11 of 21 View next.